3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators

Details for Australian Patent Application No. 2005312585 (hide)

Owner Nissan Chemical Industries, Ltd.

Inventors Yanagihara, Kazufumi; Shigeta, Yukihiro; Hirokawa, Yutaka; Ishiwata, Norihisa; Nakano, Satoshi; Miyaji, Katsuaki; Iwamoto, Shunsuke; Ota, Hirofumi; Owada, Shingo

Agent Davies Collison Cave

Pub. Number AU-B-2005312585

PCT Pub. Number WO2006/062240

Priority 2005-330891 15.11.05 JP; 2004-355195 08.12.04 JP

Filing date 7 December 2005

Wipo publication date 15 June 2006

Acceptance publication date 12 January 2012

International Classifications

C07D 333/32 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

A61K 31/415 (2006.01) - 1,2-Diazoles

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

C07D 231/18 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

Event Publications

31 May 2007 PCT application entered the National Phase

  PCT publication WO2006/062240 Priority application(s): WO2006/062240

12 January 2012 Application Accepted

  Published as AU-B-2005312585

10 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005312638-Method for producing thiocarbamate derivative

2005312559-Precoated metal plate and process for producing precoated metal plate